iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February 24

NASHUA, N.H.,
Feb. 18, 2021 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology
leader providing innovative cancer detection and therapy solutions, today
announced that it will release financial results for the fourth quarter and
year ended December 31, 2020, after the market close, and host a conference
call at 4:30pm Eastern Time on Wednesday, February 24.

About iCAD, Inc.
Headquartered
in Nashua, NH, iCAD is a global medical technology leader providing innovative
cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:

Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568